Satellos Bioscience's total assets for Q2 2026 were C$65.66M, a decrease of -12.78% from the previous quarter. DE:0IT total liabilities were C$5.85M for the fiscal quarter, a 28.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.